GENEVA, Nov. 19 -- UMOJA BIOPHARMA, INC. (1150 Eastlake Ave E., Suite 400Seattle, Washington 98109) filed a patent application (PCT/US2025/028136) for "FUSION PROTEIN FOR USE AS IMMUNE CELL ENGAGER" on May 07, 2025. With publication no. WO/2025/235604, the details related to the patent application was published on Nov 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SHIN, Seungjin, TANG, Weiliang, MCDONNELL, Mollie M., YOUN, Yong-Ha
Abstract: Disclosed herein are immune cell engagers. The immune cell engager may include a cell binding domain, an immune cell adhesion molecule, an immune c...